Synthetic biology advances drive greener production of tryptophan-based pharmaceuticals
Peer-Reviewed Publication
Updates every hour. Last Updated: 10-Jun-2026 16:16 ET (10-Jun-2026 20:16 GMT/UTC)
When AI is used to write code that interacts with so-called legacy systems with outdated software, expensive problems arise, costing U.S. companies an estimated $1.5 trillion in reduced productivity and cybercrime. Research by Edward Anderson Jr., professor of information, risk, and operations management, finds ways companies can avoid common pitfalls.
In The Physics Teacher, a physics professor-turned-AI-researcher explores the uses of generative AI to teach physical science. Gerd Kortemeyer compares the constantly increasing physics capabilities of generative AI to the boiling frog fable, which predicts that a frog will fail to recognize the danger of a gradually heating pot until it’s too late to hop out. Kortemeyer lays out situations where generative AI usage may be warranted and places where it may not help education — and therefore, a “jump out of the pot” is warranted.
Farmers and outdoor workers in the Northeast are facing an escalating threat of tick-borne diseases, which could be devastating to their livelihoods, according to new research led by Mandy Roome, associate director of the Tick-borne Disease Center at Binghamton University, State University of New York.
Advanced quantum detectors designed at Texas A&M University are reinventing the search for dark matter, an unseen force that science has yet to explain.
A Rice University-led team has unveiled how tiny molecular structures on industrial catalysts behave during the manufacture of vinyl acetate monomer (VAM), a core ingredient in adhesives, paints, coatings, packaging, textiles and many other products people use every day. By revealing how these molecular palladium-acetate trimers and dimers transform under reaction conditions and control catalyst performance, the work points the way to catalyst designs that could cut energy use, reduce carbon emissions and make global VAM production cleaner and more reliable.
A new AI model designs peptides (short proteins) that are targeted by enzymes called proteases, which are overactive in cancer cells. Nanoparticles coated with these peptides can act as sensors that signal if cancer-linked proteases are present in the body.